Delivery Order SPE2DE23D0008-SPE2D626F40HS
- Not listed
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical on November 6, 2025, for Natrelle Inspira SSM 405CC breast implants. The contract, which represents a child delivery order under a larger Indefinite Delivery Vehicle (IDV), is scheduled for completion by November 24, 2025, and will be performed at the contractor's facility in Irvine, California. The award carries no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814.00 fixed-price delivery order contract on December 2, 2025, for Natrelle Inspira SSM 310CC breast implants. This award is a child delivery order issued under one of Allergan's two significant Indefinite Delivery/Indefinite Quantity (IDV) contracts with the Defense Logistics Agency (DLA) Troop Support Medical, specifically the $13.5 million IDV for Natrelle breast implants and surgical devices established in December 2022. The...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on November 26, 2025, with completion scheduled for December 1, 2025. The contract covers the delivery of Natrelle Inspira SCM 485CC breast implants to support surgical procedures at military treatment facilities and related federal healthcare systems. This delivery order was issued without a set-aside designation, reflecting...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, with an ultimate completion date of July 24, 2025. The contract covers the supply of Natrelle Inspira SCM 375CC breast implants and will be performed in Irvine, California. This award was made without set-aside designation, reflecting Allergan's position as a specialized supplier of these medical devices to federal...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order on September 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division for 4569553905 Inspira SRF 385CC breast implants, valued at $1,110.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of September 25, 2025, and represents performance work to be completed at Allergan's facility in Irvine, California. The award utilizes no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,300 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on December 11, 2025, for Natrelle Inspira SSM 520CC breast implants. The delivery order, which carries no set-aside designation, is scheduled for completion by December 24, 2025, with performance occurring at the company's facility in Irvine, California. This award represents a child contract under one of Allergan's larger Indefinite...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,021.00 fixed-price delivery order with economic price adjustment for Natrelle Inspira SCM 375CC breast implants on July 22, 2025. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, will be performed in Irvine, California and is scheduled for completion by July 24, 2025. The contract was awarded without set-aside designation by the Medical Supply Chain division of the Defense Logistics...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $1,614.00 by the Defense Logistics Agency's Medical Supply Chain division on December 17, 2025, for Natrelle Inspira SCF 485CC breast implants. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of December 19, 2025, and will be performed in Irvine, California. The award was made without a set-aside designation, reflecting Allergan's status as a sole-source...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,075 delivery order by the Defense Logistics Agency Medical Supply Chain on September 11, 2025, for Natrelle Inspira SSF 485CC breast implants with a completion date of September 15, 2025. This fixed-price contract with economic price adjustment will be performed in Irvine, California and does not utilize a set-aside designation. The award represents a child order under one of Allergan's larger indefinite delivery vehicles,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,407 fixed-price delivery order with economic price adjustment on January 14, 2026, for Natrelle Inspira SSL 230cc breast implants. The contract, classified as a child award under a larger Indefinite Delivery/Indefinite Quantity vehicle, will be performed in Irvine, California, with an ultimate completion date of January 16, 2026. This delivery order was issued without a set-aside designation and is funded through the Defense...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D626F40HSDelivery Order
Allergan USA Inc., a subsidiary of AbbVie Inc., received a $1,200 fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical on January 15, 2026, for Natrelle Inspira SSM 520cc breast implants. This is a child contract under one of Allergan's two significant Indefinite Delivery Vehicle (IDV) contracts valued at $13.5 million for Natrelle breast implants and surgical devices, established December 8, 2022. The delivery order carries an ultimate completion date of January 20, 2026, and will be performed in Irvine, California. No small business set-aside designation was applied to this award, consistent with Allergan's status as a sole-source provider of these specialized medical devices to federal agencies. The procurement supports reconstructive and aesthetic surgical procedures across Department of Defense research centers, hospitals, and clinics, as well as VA facilities and Indian Health Service centers. The fixed-price contract with economic price adjustment structure enables the DLA Medical Supply Chain to efficiently order and fulfill Allergan's specialized breast implant products with on-site support from company representatives. Allergan has established itself as a critical supplier of medical technologies to various government healthcare systems, with a consistent track record of delivering these products to federal military treatment facilities and veteran healthcare providers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/14/26 |